Pure Global AI
NCT06352060Recruiting

Dynamic Data-Driven Management of Atrial Fibrillation Using Implantable Cardiac Monitors: The MONITOR-AF Study

Kansas City Heart Rhythm Research FoundationClinicalTrials.govother
Verified
Study focus
Disease/Condition
Atrial Fibrillation
Drug/Device/Intervention
No intervention or administration will be performed due to the observational nature of the study
Study type
Observational
Intervention type
other
Sponsor & location
Primary sponsor
Kansas City Heart Rhythm Research Foundation
Location
Overland Park,Overland Park,Overland Park,Independence,Independence,Kansas City,Kansas City, United States of America
Timeline & enrollment
Phase
N/A
Start date
Apr 01, 2024
End date
Sep 01, 2024
Enrollment
2500 participants
Primary outcome

No.of patients with arrhythmia recurrence,No.of patients with redo ablation

Summary

Observational, multi-center, retrospective study to evaluate the use of ICM (implantable
 cardiac monitor) versus traditional, non-ICM (non-implantable cardiac monitor) methods such
 as ECGs (electrocardiogram), Holter, and mobile cardiac outpatient telemetry (MCOT) units.

ICD-10 classifications
Chronic atrial fibrillationPersistent atrial fibrillationParoxysmal atrial fibrillationAtrial fibrillation and flutterAtrial fibrillation and atrial flutter, unspecified
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06352060
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06352060 through Pure Global AI's free database. This phase not specified trial is sponsored by Kansas City Heart Rhythm Research Foundation and is currently Recruiting. The study focuses on Atrial Fibrillation. Target enrollment is 2500 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.